RIL picks majority stake in Netmeds: How it became 'India ki pharmacy'

Promoted by Dadha Pharma, Netmeds is one of the earliest players in online pharmacy having incorporated in 2015

Pradeep Dadha, Founder & CEO, Netmeds.com
Pradeep Dadha, Founder & CEO, Netmeds.com
T E Narasimhan Chennai
4 min read Last Updated : Aug 19 2020 | 2:59 PM IST
Reliance Industries Ltd has acquired a majority stake in Chennai-based online pharmacy delivery startup Netmeds (Vitalic Health Pvt. Ltd) for a cash consideration of approximately Rs 620 crore. Promoted by Dadha Pharma, Netmeds is one of the earliest players in online pharmacy having incorporated in 2015.

"It is indeed a proud moment for Netmeds to join Reliance family and work together to make quality healthcare affordable and accessible to every Indian. With the combined strength of the group’s digital, retail and tech platforms, we will strive to create more value for everyone in the ecosystem, while providing a superior Omni Channel experience to consumers," said Pradeep Dadha, Founder & CEO, Netmeds.

Now, let's take a look at the success story of Netmeds from just an idea to becoming 'India Ki Pharmcy'.
 
Netmeds was founded in 2015 by Pradeep Dadha, whose family ventured into the pharmaceutical retailing business in 1914 and entered into drug manufacturing in 1972.
 
The manufacturing unit, Tamil Nadu Dadha Pharmaceuticals, was later merged with Sun Pharma in 1996. Today, the Group sells drugs in wholesale in Kerala and retail in Tamil Nadu.

Pradeep Dadha leads the Pradeep Dadha group of companies and is the chairman of Notch Media.
 
The idea of Netmeds was born when Pradeep was thinking of initiating online sales for his family business as internet penetration in India was also growing leaps and bounds, creating a favourable environment for e-commerce/ e-pharma to operate.
 
He wanted to utilise the possibility of online stores and came up with Netmeds.
 
To Pradeep Dadha's advantage, he comes from a family that has been in the pharma business for over 100 years. His grandfather, Lalchand, who founded Dadha and Co in 1914 and his father Mohanchand grew it in one of the most trusted pharma companies in South India.
 
But this does not give an edge except for the trust factor. In one of his interviews, Pradeep Dadha said the company's biggest challenge during the initial days was with the perception of the consumer that buying medicines online may not be safe.
 
The company had to build transparency and trust in its operations and process. For example. the company had pharmacists to do the due diligence just like a traditional brick and mortar pharmacy.
 
Similarly, dealing with large stock units (SKUs) and ensuring their availability across the country was also a challenge that the company faced during its initial days. The company has managed to scale the breadth of the country providing quality and affordable healthcare even to the most outlying areas.
 
Unlike most competitors Netmeds would be able to deliver drugs across the country, Dadha said in the interview. Netmeds offers a pan-India solution for the quick online purchase and fast delivery of prescription medications to over 20,000 pin codes. Netmeds has served over 5.7 million customers in more than 670 cities and towns. Consumers get access to more than 70,000 prescription drugs for chronic and recurring ailments as well as enhanced lifestyle drugs.
 
The company also used technologies like artificial intelligence and machine learning to understand customers, predict trends and build a preventive healthcare ecosystem around Netmeds.
 
"Technology helps not just our core product offering of medicines delivery, but it plays a definitive role in transforming Netmeds into a complete healthcare product and service company as we diversify into telemedicine/ online doctor consultation diagnostics and generic drugs," Dadha said.
 
The company last year roped in cricketer Mahendra Singh Dhoni as its brand ambassador.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Reliance IndustriesNetmedsIndian pharmaonline pharmacyMukesh Ambani

Next Story